: Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007, 13:332–339.PubMedCrossRef 14. Cheng Q, Aleksunes LM, Manautou JE, Cherrington NJ, Scheffer GL, Yamasaki H, Slitt AL: Drug-metabolizing selleck compound enzyme and transporter expression in a mouse model of diabetes and obesity. Mol Pharm 2008, 5:77–91.PubMedCrossRef 15. Klaassen CD, Aleksunes LM: Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 2010, 62:1–96.PubMedCrossRef 16. Hagenbuch B, Gui C: Xenobiotic transporters of the human organic anion transporting polypeptides (OATP)
family. Xenobiotica 2008, 38:778–801.PubMedCrossRef 17. Brandoni A, Torres AM: Characterization of the mechanisms involved in the increased renal elimination of bromosulfophthalein
during cholestasis: involvement of Oatp1. J Histochem Cytochem 2009, 57:449–456.PubMedCrossRef 18. Corcoran GB, Wong BK: Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat. J Pharmacol Exp Ther 1987, 241:921–927.PubMed 19. Lickteig AJ, Fisher CD, Augustine LM, Aleksunes LM, Besselsen DG, Slitt AL, Manautou JE, Cherrington EPZ-6438 mouse NJ: Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. Drug Metab Dispos 2007, 35:1970–1978.PubMedCrossRef 20. Corcoran GB, Salazar DE, Chan HH: Obesity as a risk factor in drug-induced organ injury. III. Increased liver and kidney injury by furosemide
in the obese overfed rat. Toxicol Appl Pharmacol 1989, 98:12–24.PubMedCrossRef 21. Corcoran GB, Salazar DE: Obesity as a risk factor in drug-induced organ injury. IV. Increased gentamicin nephrotoxicity in the obese overfed rat. J Pharmacol Exp Ther 1989, 248:17–22.PubMed 22. Barshop NJ, Capparelli EV, Sirlin CB, Schwimmer JB, Lavine JE: Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease. Y-27632 2HCl J Pediatr Gastroenterol Nutr 2011, 52:198–202.PubMedCrossRef 23. Cheng X, Maher J, Chen C, Klaassen CD: Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps). Drug Metab Dispos 2005, 33:1062–1073.PubMedCrossRef 24. Maher JM, Aleksunes LM, Dieter MZ, Tanaka Y, Peters JM, Manautou JE, Klaassen CD: Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Toxicol Sci 2008, 106:319–328.PubMedCrossRef 25. Zamek-Gliszczynski MJ, Nezasa K, Tian X, Bridges AS, Lee K, Belinsky MG, Kruh GD, Brouwer KL: Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3−/− and Abcc4−/− mice. J Pharmacol Exp Ther 2006, 319:1485–1491.PubMedCrossRef 26.